Priska Pharma Private Limited, a active private limited company, was established on 04 February 2015 in New Delhi, Delhi, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24100DL2015PTC276308. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Amod Kumar (Director), Vikash Pandey (Director), Kundan Kumar (Additional Director). Past directors included Abhishek Singh, Umesh Prasad Singh, Nitin Sharma. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No- 211 S/F Som Dutt Chamber Ii, 9 Bhikaji Cama Place, Near Hayat Hotel, New Delhi, Delhi, 110066.
U24100DL2015PTC276308
276308
04 February 2015
₹5.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Priska Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amod Kumar | Director | 21 Jan 2023 | Current |
| Vikash Pandey | Director | 21 Jan 2023 | Current |
| Kundan Kumar | Additional Director | 31 Aug 2024 | Current |
| Ajeet Kumar | Additional Director | 31 Aug 2024 | Current |
| Manas Kumar Sircar | Additional Director | 25 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jul 2020 | Past |
| Pramod Abcsdd | Director | 23 Jun 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Priska Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.87% increase. The company also saw a slight improvement in profitability, with a 5.67% increase in profit. The company's net worth Soared by an impressive increase of 24.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Priska Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Priska Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Priska Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Priska Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Manas Kumar Sircar was appointed as a Additional Director was appointed as a Additional Director on 25 Apr 2025 & has been associated with this company since 7 months 8 days . was completed.
Priska Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Kundan Kumar was appointed as a Additional Director was appointed as a Additional Director on 31 Aug 2024 & has been associated with this company since 1 year 3 months . was documented.
Ajeet Kumar was appointed as a Additional Director was appointed as a Additional Director on 31 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The activity Priska Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Amod Kumar was appointed as a Director was appointed as a Director on 21 Jan 2023 & has been associated with this company since 2 years 10 months . was completed.
The CIN of Priska Pharma Private Limited is U24100DL2015PTC276308.
Priska Pharma Private Limited is headquartered at H.No- 211 S/F Som Dutt Chamber Ii, 9 Bhikaji Cama Place, Near Hayat Hotel, New Delhi, Delhi, 110066.
Priska Pharma Private Limited was incorporated on 04 February 2015.
The current directors of Priska Pharma Private Limited are
The primary industry of Priska Pharma Private Limited is Hospital And Medical Care.
Priska Pharma Private Limited is unlisted.
The authorized capital of Priska Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Priska Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX